KEAN BEIERSCHMITT: Open Payments
NPI 1225339518 · NEW BERN, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$771 in 41 payments from 18 companies in 2025. Trend: 2023 $192 · 2024 $708 · 2025 $771
Food & beverage: $771
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $301 |
| SANOFI-AVENTIS U.S. LLC | 2 | $48 |
| TOLMAR, INC. | 2 | $46 |
| Fresenius Kabi USA, LLC | 3 | $45 |
| Neurocrine BioSciences, Inc. | 2 | $40 |
| CSL Behring | 2 | $39 |
| E.R. Squibb & Sons, L.L.C. | 2 | $36 |
| Madrigal Pharmaceuticals | 1 | $33 |
| Novo Nordisk Inc | 2 | $32 |
| UCB, Inc. | 1 | $31 |
Products named: SKYRIZI, RINVOQ, TZIELD, JATENZO, INGREZZA, Hizentra, ORENCIA, REZDIFFRA.
Industry payments across NC — which companies pay providers there.
